Cargando…

Comment on “EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach”

Detalles Bibliográficos
Autores principales:	Vigneswaran, Wickii T., Kittaneh, Muaiad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815355/ https://www.ncbi.nlm.nih.gov/pubmed/33489811 http://dx.doi.org/10.21037/tlcr-2020-14

Ejemplares similares

Malignant Pleural Mesothelioma: Current Understanding of the Immune Microenvironment and Treatments of a Rare Disease
por: Tedesco, John, et al.
Publicado: (2022)

Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee
por: Pass, Harvey I., et al.
Publicado: (2014)

Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members
por: Kittaneh, Muaiad, et al.
Publicado: (2018)

Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015)

Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report
por: Pezzuto, Federica, et al.
Publicado: (2021)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2014)

Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women
por: Kittaneh, Muaiad, et al.
Publicado: (2011)

Clinical significance of histologic subtyping of malignant pleural mesothelioma
por: Brcic, Luka, et al.
Publicado: (2020)

EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma
por: Tan, Yi-Hung Carol, et al.
Publicado: (2019)

Diagnosis and Treatment of Pineal Region Tumors in Adults: A EURACAN Overview
por: Lombardi, Giuseppe, et al.
Publicado: (2022)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022)

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
por: Bibby, Anna C., et al.
Publicado: (2016)

New Insights in Pleural Mesothelioma Classification Update: Diagnostic Traps and Prognostic Implications
por: Mastromarino, Maria Giovanna, et al.
Publicado: (2022)

Malignant acrospiroma: a case report in the era of next generation sequencing
por: Diab, Maria, et al.
Publicado: (2017)

Rethought histologic classification of pleural mesothelioma to better treat: go forward from looking back
por: Astoul, Philippe
Publicado: (2020)

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification
por: Shimada, Yoshihisa, et al.
Publicado: (2013)

Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification
por: Boukansa, Sara, et al.
Publicado: (2022)

Molecular Profiling for Breast Cancer: A Comprehensive Review
por: Kittaneh, Muaiad, et al.
Publicado: (2013)

BAP1: role in carcinogenesis and clinical implications
por: Kobrinski, Daniel A., et al.
Publicado: (2020)

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma
por: Carey, George B, et al.
Publicado: (2012)

Clinical, Laboratory, Histological, Radiological, and Metabolic Features and Prognosis of Malignant Pleural Mesothelioma
por: Zhang, Yuan, et al.
Publicado: (2022)

Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study
por: Saracino, Laura, et al.
Publicado: (2021)

IASLC Textbook of Prevention and Early Detection of Lung Cancer
por: Spiro, S G
Publicado: (2006)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients
por: Wang, Tengteng, et al.
Publicado: (2017)

Histologic classification and differential diagnosis of mesothelioma.
por: Carter, D.
Publicado: (1981)

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
por: Cedres, Susana, et al.
Publicado: (2021)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Proposal for a new local recurrence score in patients with recurrent malignant pleural mesothelioma
por: Lauk, Olivia, et al.
Publicado: (2022)

Antihistamine-Induced Hepatitis: 2 Cases Involving Loratidine
por: Arshad, Hafiz, et al.
Publicado: (2016)

Malignant Gastrointestinal Neuroectodermal Tumor (GNET) with Prolonged Disease-Free Survival after Platinum-Based Chemotherapy
por: Singh, Daulath, et al.
Publicado: (2020)

Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis
por: Gao, Ruiyue, et al.
Publicado: (2019)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Pleural mesothelioma – case report
por: Klawiter, Anna, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uabtsst2audrp8flelve1bfqcd